%0 Journal Article
%K Administration, Inhalation
%K Adrenal Cortex Hormones
%K Adrenergic beta-2 Receptor Agonists/adverse effects
%K *Asthma/drug therapy
%K Beclomethasone/therapeutic use
%K Budesonide, Formoterol Fumarate Drug Combination/therapeutic use
%K Formoterol Fumarate/therapeutic use
%K Humans
%K Muscarinic Antagonists/therapeutic use
%K Primary health care
%K *Pulmonary Disease, Chronic Obstructive/drug therapy
%K Retrospective Studies
%K COPD epidemiology
%K COPD pharmacology
%K inhaler devices
%B BMJ Open Respir Res
%D 2022
%G eng
%M 36171051
%R 10.1136/bmjresp-2022-001243
%T Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England
%V 9
%2 PMC9528685
%7 2022/09/29
%@ 2052-4439